Heartsciences Inc (HSCS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 01-2026 | 10-2025 | 07-2025 | 04-2025 | 01-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,391 | -4,406 | -2,055 | -8,765 | -6,671 |
| Depreciation Amortization | 493 | 438 | 142 | 414 | 273 |
| Accounts receivable | 4 | 4 | 4 | -4 | N/A |
| Accounts payable and accrued liabilities | 92 | -1 | -35 | -130 | -43 |
| Other Working Capital | -948 | -961 | -215 | 519 | 412 |
| Other Operating Activity | 999 | 638 | 206 | 553 | 207 |
| Operating Cash Flow | $-5,750 | $-4,288 | $-1,953 | $-7,413 | $-5,822 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -13 | N/A | -3 | -3 |
| Purchase Sale Intangibles | -41 | -4 | -1 | -27 | -19 |
| Other Investing Activity | -41 | -4 | -1 | -27 | -19 |
| Investing Cash Flow | $-45 | $-17 | $-1 | $-30 | $-22 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,000 | N/A | N/A | 1,850 | 1,850 |
| Debt Repayment | -629 | -565 | -148 | -264 | -193 |
| Common Stock Issued | 173 | 173 | N/A | 1,148 | 976 |
| Other Financing Activity | 5,549 | 5,549 | 3,796 | 0 | 0 |
| Financing Cash Flow | $8,094 | $5,157 | $3,648 | $2,734 | $2,634 |
| Beginning Cash Position | 1,098 | 1,098 | 1,098 | 5,808 | 5,808 |
| End Cash Position | 3,397 | 1,951 | 2,792 | 1,098 | 2,597 |
| Net Cash Flow | $2,299 | $853 | $1,694 | $-4,710 | $-3,211 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,750 | -4,288 | -1,953 | -7,413 | -5,822 |
| Capital Expenditure | -4 | -13 | N/A | -3 | -3 |
| Free Cash Flow | -5,754 | -4,301 | -1,953 | -7,416 | -5,826 |